Nolicin (Norfloxacin)

Norfloxacin is a fluoroquinolone antibiotic used to treat bacterial infections affecting several organ systems.

• Uncomplicated urinary tract infection: eradicates the causative bacteria, relieving symptoms and preventing recurrence.
• Acute prostatitis: achieves bacterial clearance in the prostate, reducing inflammation and pain.
• Traveler’s diarrhea (gastrointestinal infection): controls bacterial overgrowth, alleviating diarrhoea and abdominal discomfort.
• Respiratory tract infection: eliminates susceptible pathogens, improving cough, fever and breathing difficulties.

• Norfloxacin exerts its antibacterial effect by binding to the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV. Inhibition of these enzymes prevents the supercoiling and separation of DNA strands required for replication and transcription. The resulting disruption of DNA synthesis leads to rapid bacterial cell death, particularly against Gram‑negative organisms and some Gram‑positive strains.

Norfloxacin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild stomach upset often occurring after the dose.
• Diarrhoea: loose stools that may be self‑limiting.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.
• Abdominal pain: cramp‑like discomfort in the stomach area.
• Rash: mild skin redness or itching.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles.
• QT interval prolongation: heart rhythm disturbances that may cause palpitations.
• Severe allergic reactions: anaphylaxis, swelling of face or throat.
• Clostridioides difficile infection: severe colitis with watery diarrhoea.
• Hepatic dysfunction: jaundice or elevated liver enzymes.
• Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing norfloxacin, clinicians should evaluate patient‑specific factors and follow safety recommendations.

• Renal impairment: adjust dose or avoid in severe kidney dysfunction.
• Hepatic impairment: monitor liver function and consider dose modification.
• History of tendon disorders: avoid use in patients with previous tendon injury or tendonitis.
• Concomitant antacids or supplements: separate administration by at least 2 hours to prevent reduced absorption.
• Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited.
• Elderly patients: increased risk of CNS effects; monitor closely.
• Store below 25°C: keep in the original container, protect from moisture and light.

Norfloxacin can interact with several medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid)

• Antacids containing aluminium or magnesium: markedly reduce norfloxacin absorption.
• Warfarin: may enhance anticoagulant effect, increasing bleeding risk.
• Corticosteroids: combined use raises risk of tendon rupture.
• Theophylline: can increase theophylline plasma concentrations.
• Cyclosporine: may raise cyclosporine levels, leading to nephrotoxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs: concurrent use may increase risk of central nervous system stimulation.
• Sulfonylureas: may potentiate hypoglycaemia.
• QT‑prolonging agents: additive effect on cardiac repolarisation.
• Diabetic agents: monitor blood glucose as fluoroquinolones may affect control.